ULBP2 Antibodies

Santa Cruz Biotechnology features a diverse variety of ULBP2 monoclonal antibodies for research in understanding ULBP2's role in immune response and tumor biology. ULBP2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ULBP2, or UL16 binding protein 2, is a member of the NKG2D ligand family and plays a crucial role in the activation of natural killer (NK) cells and T cells. By binding to the NKG2D receptor on immune cells, ULBP2 enhances the immune system's ability to recognize and eliminate stressed or malignant cells. Understanding ULBP2 function is vital for developing immunotherapeutic strategies against cancer and other diseases. ULBP2 monoclonal antibodies enable researchers to explore cellular pathways involved in immune regulation. Investigating ULBP2 expression patterns helps reveal its role in various physiological and pathological conditions. Research with ULBP2 monoclonal antibodies contributes to understanding immune system responses in different disease states. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of immune system regulation and potential therapeutic applications.